Merck KGaA Stock

Merck KGaA P/S 2024

Merck KGaA P/S

3.38

Ticker

MRK.DE

ISIN

DE0006599905

WKN

659990

As of Nov 25, 2024, Merck KGaA's P/S ratio stood at 3.38, a -0.59% change from the 3.4 P/S ratio recorded in the previous year.

The Merck KGaA P/S history

Merck KGaA Aktienanalyse

What does Merck KGaA do?

Merck is one of the oldest and most well-known companies in the pharmaceutical and chemical industry. It was founded as a pharmacy in Darmstadt in 1668 and has since developed into a global company that is successful worldwide. Merck's business model is based on various business areas, all of which are based on scientific research and innovation. The three main business areas are the Life Science, Healthcare, and Performance Materials divisions, all of which focus on providing products and services for a wide range of industries. Life Science is Merck's largest business area, focusing on providing materials, products, instruments, and services for scientific research and biopharmaceutical production. The company offers a wide range of products that focus on the work of researchers and scientists in molecular biology, cell technology, and genomics. Healthcare is another important business area for Merck, focusing on the manufacture and marketing of innovative drugs and treatments for patients. The company offers products for the treatment of diseases such as cancer, multiple sclerosis, and schizophrenia. Performance Materials is Merck's third business area, specializing in the production of materials and technologies for various industries such as the automotive industry, electronics, and packaging. The company focuses on the development of innovative materials such as liquid crystals and organic photovoltaic materials. Merck is also known for its research and development, and the company invests significant resources in developing new products and technologies. This is also evident in the extensive portfolio of products offered by Merck. The company offers a wide range of products ranging from laboratory and analysis equipment to pharmaceuticals and biopharmaceuticals to specialty chemicals. An example of an important product from Merck is the rheumatoid arthritis drug Remicade, which was developed in collaboration with Johnson & Johnson. Merck is also one of the leading manufacturers of liquid crystals for use in displays and electronic devices. Merck is a company committed to social responsibility and sustainability. The company is involved in many areas, including environmental, social, and governance issues. Merck is committed to developing sustainable products and technologies and is dedicated to promoting education, health, and social justice in the communities where it operates. Overall, Merck is a leading company in the pharmaceutical and chemical industry, known for its innovation, research and development, as well as its social responsibility and sustainability. With currently approximately 58,000 employees and annual sales of 17.4 billion euros, the global company network is represented in 67 countries and demonstrates the quality and capabilities of the company worldwide. Merck KGaA ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Merck KGaA revenue by segment

  • 42 % Life Science

  • 42 % Healthcare

  • 16 % Performance Materials

P/S Details

Decoding Merck KGaA's P/S Ratio

Merck KGaA's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Merck KGaA's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Merck KGaA's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Merck KGaA’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Merck KGaA stock

What is the price-to-earnings ratio of Merck KGaA?

The price-earnings ratio of Merck KGaA is currently 3.38.

How has the price-earnings ratio of Merck KGaA changed compared to last year?

The price-to-earnings ratio of Merck KGaA has increased by -0.59% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Merck KGaA high compared to other companies?

Yes, the price-to-earnings ratio of Merck KGaA is high compared to other companies.

How does an increase in the price-earnings ratio of Merck KGaA affect the company?

An increase in the price-earnings ratio of Merck KGaA would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Merck KGaA affect the company?

A decrease in the price-earnings ratio of Merck KGaA would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Merck KGaA?

Some factors that influence the price-earnings ratio of Merck KGaA are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Merck KGaA pay?

Over the past 12 months, Merck KGaA paid a dividend of 2.2 EUR . This corresponds to a dividend yield of about 1.55 %. For the coming 12 months, Merck KGaA is expected to pay a dividend of 2.42 EUR.

What is the dividend yield of Merck KGaA?

The current dividend yield of Merck KGaA is 1.55 %.

When does Merck KGaA pay dividends?

Merck KGaA pays a quarterly dividend. This is distributed in the months of May, May, June, May.

How secure is the dividend of Merck KGaA?

Merck KGaA paid dividends every year for the past 26 years.

What is the dividend of Merck KGaA?

For the upcoming 12 months, dividends amounting to 2.42 EUR are expected. This corresponds to a dividend yield of 1.7 %.

In which sector is Merck KGaA located?

Merck KGaA is assigned to the 'Health' sector.

Wann musste ich die Aktien von Merck KGaA kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Merck KGaA from 5/2/2024 amounting to 2.2 EUR, you needed to have the stock in your portfolio before the ex-date on 4/29/2024.

When did Merck KGaA pay the last dividend?

The last dividend was paid out on 5/2/2024.

What was the dividend of Merck KGaA in the year 2023?

In the year 2023, Merck KGaA distributed 1.85 EUR as dividends.

In which currency does Merck KGaA pay out the dividend?

The dividends of Merck KGaA are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Merck KGaA stock can be added to a savings plan with the following providers: Trade Republic, ING, Scalable Capital and Consorsbank

Andere Kennzahlen von Merck KGaA

Our stock analysis for Merck KGaA Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Merck KGaA Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.